Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201877
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2005-09-12
Brief Title:
Velcade Bortezomib PS-341 and Rituximab in RelapsedRefractory Mantle Cell and Follicular Non-Hodgkins Lymphoma
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center